gabexate has been researched along with Chronic Lung Injury in 3 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshikawa, S | 1 |
| Tsushima, K | 1 |
| Koizumi, T | 1 |
| Kubo, K | 1 |
| Luh, SP | 1 |
| Tsai, CC | 1 |
| Shau, WY | 1 |
| Shiau, SY | 1 |
| Jan, IS | 1 |
| Kuo, SH | 1 |
| Yang, PC | 1 |
| Niehaus, GD | 1 |
| Kimura, R | 1 |
| Traber, LD | 1 |
| Herndon, DN | 1 |
| Flynn, JT | 1 |
| Traber, DL | 1 |
3 other studies available for gabexate and Chronic Lung Injury
| Article | Year |
|---|---|
Effects of a synthetic protease inhibitor (gabexate mesilate) and a neutrophil elastase inhibitor (sivelestat sodium) on acid-induced lung injury in rats.
Topics: Animals; Bronchoalveolar Lavage Fluid; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, C | 2010 |
Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors.
Topics: Administration, Inhalation; Animals; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Capillary Per | 2002 |
Administration of a synthetic antiprotease reduces smoke-induced lung injury.
Topics: alpha-Macroglobulins; Animals; Endopeptidases; Female; Gabexate; Guanidines; Lung Injury; Neutrophil | 1990 |